Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Avila Therapeutics Inc.

Headquarters: Bedford, MA, United States of America
Website: N/A
Year Founded: 2007
Status: Acquired

BioCentury | May 26, 2022
Management Tracks

Ex-Editas CEO Bosley among Advent’s new hires

U.K.-based VC taps Bosley, BioMotiv’s Jindal as it builds U.S. team; hires Syncona’s Schmidt in U.K.
BioCentury | Dec 8, 2014
Finance

Polaris hunts problems and solutions

How Polaris plans to spend new $450M hybrid fund
BioCentury | Dec 8, 2014
Clinical News

Rociletinib: Phase I/II data

BioCentury | Nov 3, 2014
Finance

Fresh fund, same plan

Advent sticking with investment strategy for L145.5M second life sciences fund
BioCentury | Oct 6, 2014
Finance

Atlas' next chapter

What splitting from tech team means for Atlas life science portfolio
BioCentury | Jul 14, 2014
Clinical News

CO-1686: Phase II started

BioCentury | Jun 30, 2014
Company News

Editas Medicine management update

BioCentury | Jun 25, 2014
Company News

Editas names Bosley CEO

BioCentury | Jun 9, 2014
Clinical News

AVL-301: Additional Phase I/II data

BioCentury | May 26, 2014
Clinical News

AVL-301 regulatory update

Items per page:
1 - 10 of 67